Dr. Mark Lloyd: Transforming Pathology with Digital Innovation at Fujifilm

36

TL/DR –

Dr Mark Lloyd has extensive experience in digital pathology, working for over 20 years in the field and currently leading Fujifilm’s digital pathology division. During his career, he developed the first digital pathology system patent by mounting digital cameras on microscopes, and later founded a successful company in the industry. Lloyd discussed the challenges in the adoption of digital pathology due to differences in healthcare systems across countries and the role of AI in the future of the field.


Dr Mark Lloyd’s Impact in Digital Pathology

Dr. Mark Lloyd, head of Fujifilm’s digital pathology division, has spent over two decades in the field, prioritising innovation, entrepreneurship, and patient care improvements. His journey began in a disorganised laboratory environment, inspiring him to make significant changes.

During an internship at the National Institutes of Health, Lloyd developed the first digital pathology system. He continued his impactful work at Georgetown University and Moffitt Cancer Center in Florida, scaling digital pathology for clinical use. Following the acquisition of Inspirata’s digital pathology business, Lloyd joined Fujifilm with a goal to positively impact a billion lives.

Challenges in Digital Pathology Industry

The digitisation of pathology is rapidly spreading globally, creating a significant impact on patient care. However, in the US, the challenge lies in obtaining appropriate reimbursement codes. The American Medical Association is working on this issue as the lack of clear funding pathways often hinders smaller hospitals’ investment in innovative technology.

Fujifilm’s Role in Overcoming Industry Challenges

Fujifilm is strategically positioned to alleviate these challenges, offering return on investment through reduced diagnosis times and preventing specimen loss among other benefits. The company’s approach is focused on tailoring solutions to each hospital’s unique needs and demonstrating the benefits of digital pathology. They believe that future reimbursement code changes will accelerate digital pathology adoption in US healthcare.

AI’s Role in Digital Pathology

AI plays a crucial role in the success of digital pathology. As we transition from paper and glass slides to digital data, AI tools can now be used to support doctors with tasks such as malignancy detection and quality control. Lloyd is confident that AI is a transformative tool that will continue to enhance pathologist support.

Overcoming Career Challenges

Lloyd acknowledges that getting an innovative technology off the ground is challenging. Transferring an idea from the lab to the commercial world requires a clear vision convincing others of its worth. Drawing from his personal journey, he underlines the importance of mentors in overcoming these hurdles.

Personal Experiences Impacting Patient Care

Personal experiences with serious illnesses have shaped Lloyd’s approach to patient care. He has seen the emotional toll of waiting for a diagnosis and is passionate about improving diagnostic speed and accuracy to lessen this burden for patients.

Impactful Technologies

The most valued technology for Lloyd is his mobile phone, which he likens to “pocket magic.” He is amazed at the ability to connect with loved ones anywhere, anytime. He extends this concept to healthcare, emphasizing the power of telemedicine and telepathology in transforming patient care.

Recharging Outside Work

Beyond work, Lloyd recharges by disconnecting and immersing himself in outdoor activities such as hiking, canoeing, or diving. These vacations are his way to rejuvenate and come back feeling refreshed.


Read More Health & Wellness News ; US News